|
humans |
36 |
|
female |
29 |
|
adult |
24 |
|
male |
21 |
|
pregnancy |
21 |
|
polycystic ovary syndrome |
15 |
|
hong kong |
13 |
|
misoprostol |
13 |
|
chinese women |
12 |
|
infertility |
11 |
|
mifepristone |
11 |
|
adolescent |
10 |
|
asian continental ancestry group |
10 |
|
cell line |
10 |
|
dysglycaemia |
10 |
|
fertilization |
10 |
|
fertilization in vitro |
10 |
|
human spermatozoa |
10 |
|
pregnancy rate |
10 |
|
time factors |
10 |
|
acrosome reaction |
9 |
|
chinese |
9 |
|
fallopian tubes - metabolism |
9 |
|
intimate partner violence |
9 |
|
middle aged |
9 |
|
ovulation induction |
9 |
|
spermatozoa |
9 |
|
adrenomedullin - genetics - metabolism |
8 |
|
calcitonin receptor-like protein |
8 |
|
cell communication - physiology |
8 |
|
cilia - metabolism - physiology |
8 |
|
embryo transfer |
8 |
|
epithelium - metabolism - physiology |
8 |
|
estradiol - blood |
8 |
|
frozen-thawed embryo transfer |
8 |
|
gene expression regulation - drug effects |
8 |
|
glycoproteins - physiology |
8 |
|
hormones - metabolism - pharmacology |
8 |
|
intracellular signaling peptides and proteins - genetics - metabolism |
8 |
|
ivf |
8 |
|
letrozole |
8 |
|
maternal age |
8 |
|
medical sciences |
8 |
|
membrane proteins - genetics - metabolism |
8 |
|
menstrual cycle - genetics - metabolism - physiology |
8 |
|
models, biological |
8 |
|
ovarian stimulation |
8 |
|
pregnancy outcome |
8 |
|
prospective studies |
8 |
|
receptor activity-modifying proteins |
8 |
|
receptors, calcitonin - genetics - metabolism |
8 |
|
spermatozoa - metabolism - physiology |
8 |
|
age‐specific reference range |
7 |
|
anti-mullerian hormone |
7 |
|
anti‐müllerian hormone |
7 |
|
automated chemiluminescence assay |
7 |
|
counseling |
7 |
|
culture |
7 |
|
endometrium |
7 |
|
glycodelin |
7 |
|
homozygote |
7 |
|
motility |
7 |
|
ovarian response |
7 |
|
ulipristal acetate |
7 |
|
wnt proteins - physiology |
7 |
|
zona pellucida |
7 |
|
adrenomedullin |
6 |
|
age |
6 |
|
angiogenesis |
6 |
|
antral follicle count |
6 |
|
apoptosis |
6 |
|
capacitation |
6 |
|
cell-signaling pathways |
6 |
|
chromosome deletion |
6 |
|
cryopreservation |
6 |
|
eg-vegf |
6 |
|
endocrinology pharmacy and pharmacology |
6 |
|
extracellular matrix proteins - physiology |
6 |
|
fallopian tube |
6 |
|
fallopian tubes - cytology - metabolism |
6 |
|
fasting glucose |
6 |
|
gestational age |
6 |
|
in vitro fertilization |
6 |
|
intracytoplasmic sperm injection |
6 |
|
invasion |
6 |
|
medical abortion |
6 |
|
menotropins - therapeutic use |
6 |
|
morphology |
6 |
|
obstetrics and gynecology medical sciences |
6 |
|
olfactomedin-1 |
6 |
|
oral glucose tolerance test |
6 |
|
pkr1 |
6 |
|
pkr2 |
6 |
|
pregnancy - blood |
6 |
|
pregnancy, tubal - physiopathology |
6 |
|
progesterone receptor |
6 |
|
retrospective studies |
6 |
|
sperm injections, intracytoplasmic |
6 |
|
sperm motility |
6 |
|
steroid receptors |
6 |
|
treatment outcome |
6 |
|
tubal ectopic pregnancy |
6 |
|
utmvec-myo |
6 |
|
wnt signaling |
6 |
|
zona pellucida binding |
6 |
|
25-hydroxyvitamin d |
5 |
|
abortion, induced - methods |
5 |
|
acupuncture |
5 |
|
adiposity |
5 |
|
androgen |
5 |
|
angiopoietin |
5 |
|
animals |
5 |
|
anti-mullerian hormone - blood |
5 |
|
antigens, cd - genetics - metabolism |
5 |
|
antigens, differentiation, myelomonocytic - genetics - metabolism |
5 |
|
anti‐mullerian hormone |
5 |
|
assisted reproduction |
5 |
|
biochemical profile |
5 |
|
biological markers - blood |
5 |
|
birth control medical sciences |
5 |
|
body weight |
5 |
|
body-mind-spirit |
5 |
|
cancer |
5 |
|
casa |
5 |
|
cells, cultured |
5 |
|
choristoma - metabolism - pathology |
5 |
|
ciliary beat |
5 |
|
cumulus oophorus |
5 |
|
differentiation |
5 |
|
dose-response relationship, drug |
5 |
|
down syndrome |
5 |
|
down syndrome - blood |
5 |
|
embryo cryopreservation |
5 |
|
embryo implantation |
5 |
|
embryo implantation - genetics |
5 |
|
embryo research - legislation & jurisprudence |
5 |
|
embryo, mammalian |
5 |
|
endocrine glands |
5 |
|
endometrial attachment |
5 |
|
endometrial receptivity |
5 |
|
endometriosis |
5 |
|
endometriosis - metabolism - pathology |
5 |
|
endometrium - cytology - metabolism |
5 |
|
endometrium - drug effects - metabolism |
5 |
|
extracellular signal-regulated map kinases - genetics - metabolism |
5 |
|
fertility preservation |
5 |
|
follicle stimulating hormone - blood |
5 |
|
frozen embryo transfer |
5 |
|
fucosyltransferase |
5 |
|
fusion |
5 |
|
glutathione peroxidase |
5 |
|
glycoproteins - genetics - metabolism |
5 |
|
gonadotrophin dosing |
5 |
|
hcg |
5 |
|
human fallopian tube |
5 |
|
human trophoblast |
5 |
|
immunoassay |
5 |
|
implantation |
5 |
|
in vitro fertilsation |
5 |
|
in-vitro fertilization |
5 |
|
injections, intramuscular |
5 |
|
intercellular signaling peptides and proteins - biosynthesis |
5 |
|
ishikawa cell line |
5 |
|
laser-captured microdissection |
5 |
|
levonorgestrel |
5 |
|
matrix metalloproteinase |
5 |
|
menstrual cycle |
5 |
|
mental health |
5 |
|
metformin |
5 |
|
miscarriage |
5 |
|
mitochondria |
5 |
|
muscular contraction |
5 |
|
natural cycle |
5 |
|
natural cycles |
5 |
|
obstetric/gynecology patients |
5 |
|
obstetrics and gynecology |
5 |
|
oocyte cryopreservation |
5 |
|
ovarian stromal blood flow |
5 |
|
oviductal epithelial cell |
5 |
|
ovulation induction - adverse effects |
5 |
|
ovulation induction - adverse effects - methods |
5 |
|
ovulation induction - methods |
5 |
|
oxidative stress |
5 |
|
pk1 |
5 |
|
placentation - drug effects - physiology |
5 |
|
polymerase chain reaction |
5 |
|
pregnancy proteins - physiology |
5 |
|
pregnancy trimester, first |
5 |
|
pregnancy trimester, second |
5 |
|
preimplantation diagnosis |
5 |
|
premature ovarian failure |
5 |
|
prenatal diagnosis |
5 |
|
prevalence |
5 |
|
primary endometrial cell culture |
5 |
|
progesterone |
5 |
|
progesterone elevation |
5 |
|
psychological abuse |
5 |
|
psychosocial intervention |
5 |
|
quality of life |
5 |
|
questionnaires |
5 |
|
reproductive techniques, assisted - ethics - legislation & jurisprudence - standards |
5 |
|
research |
5 |
|
risk factor |
5 |
|
risk factors |
5 |
|
semen |
5 |
|
socioeconomic factors |
5 |
|
sperm cryopreservation |
5 |
|
sperm fucosyltransferase-5 |
5 |
|
sperm function |
5 |
|
spheroids |
5 |
|
stimulated cycles |
5 |
|
sublingual |
5 |
|
superoxide dismutase |
5 |
|
three-dimensional ultrasound |
5 |
|
trophoblast |
5 |
|
trophoblasts - metabolism |
5 |
|
up-regulation - physiology |
5 |
|
urokinase plasminogen activator |
5 |
|
vaginal misoprostol |
5 |
|
vascular endothelial growth factor, endocrine-gland-derived - biosynthesis |
5 |
|
vegf |
5 |
|
vitamin d |
5 |
|
wnt-signaling |
5 |
|
abortifacient agents, nonsteroidal - administration & dosage - adverse effects |
4 |
|
abortifacient agents, nonsteroidal - pharmacokinetics |
4 |
|
abortion, induced |
4 |
|
abuse assessment screen |
4 |
|
acetic acid |
4 |
|
acetic acid - pharmacokinetics |
4 |
|
acrosome reaction - drug effects - physiology |
4 |
|
adenosine triphosphate - metabolism |
4 |
|
adhesions |
4 |
|
adrenomedullin - pharmacology |
4 |
|
advanced glycation end-products |
4 |
|
afc |
4 |
|
afp |
4 |
|
alleles |
4 |
|
alpha-fetoprotein |
4 |
|
alpha-thalassemia - diagnosis - embryology - genetics |
4 |
|
alpha-thalassemia - diagnosis - genetics |
4 |
|
amino acid sequence |
4 |
|
amniotic fluid |
4 |
|
androgen receptor |
4 |
|
anti-mullerian hormone - analysis - blood |
4 |
|
anti-möllerian hormone |
4 |
|
anti-müllerian hormone |
4 |
|
anti-obesity drugs |
4 |
|
antimullerian hormone |
4 |
|
art |
4 |
|
asians |
4 |
|
asthenozoospermia - metabolism - pathology |
4 |
|
attachment |
4 |
|
attitude |
4 |
|
automated chemiluminescence |
4 |
|
battered women - statistics and numerical data |
4 |
|
beta-thalassemia - diagnosis - genetics |
4 |
|
blastomere |
4 |
|
blastomeres |
4 |
|
blastula - metabolism |
4 |
|
cag repeat |
4 |
|
calcitonin gene-related peptide - pharmacology |
4 |
|
carbonyl cyanide p-trifluoromethoxyphenylhydrazone - pharmacology |
4 |
|
case-control studies |
4 |
|
child abuse - psychology - statistics & numerical data |
4 |
|
child abuse and neglect |
4 |
|
child, preschool |
4 |
|
chinese culture |
4 |
|
chorionic gonadotropin - therapeutic use |
4 |
|
chorionic gonadotropin, beta subunit, human - blood |
4 |
|
chromosome, human, y |
4 |
|
chronic pain |
4 |
|
combined injectable contraceptive |
4 |
|
combined oral contraceptive |
4 |
|
contraceptives, oral, combined - pharmacology |
4 |
|
controlled ovarian stimulation |
4 |
|
counselling |
4 |
|
cumulative live birth |
4 |
|
cumulative live-birth |
4 |
|
cumulus cells - physiology |
4 |
|
deletion |
4 |
|
depression |
4 |
|
depression, postpartum - epidemiology - psychology |
4 |
|
development |
4 |
|
dhea |
4 |
|
dilution linearity |
4 |
|
dna, mitochondrial - genetics - isolation & purification |
4 |
|
dna, mitochondrial - metabolism |
4 |
|
doppler |
4 |
|
down syndrome - blood - diagnosis |
4 |
|
down's syndrome |
4 |
|
drug evaluation, preclinical |
4 |
|
embryo culture techniques |
4 |
|
embryonic development |
4 |
|
endocrinology |
4 |
|
endometrial and subendometrial vascularity |
4 |
|
endometrial injury |
4 |
|
endometrium - metabolism |
4 |
|
energy metabolism |
4 |
|
enzyme-linked immunosorbent assay |
4 |
|
erp57 |
4 |
|
extracellular matrix - physiology |
4 |
|
extracellular matrix proteins - chemistry - genetics - metabolism |
4 |
|
extracellular signal regulated kinase |
4 |
|
extracellular vesicles |
4 |
|
family characteristics |
4 |
|
family planning service provision |
4 |
|
female reproductive tract |
4 |
|
fertility |
4 |
|
fet |
4 |
|
first trimester |
4 |
|
follicle |
4 |
|
follicular fluid |
4 |
|
follow-up studies |
4 |
|
freeze-thaw stability |
4 |
|
galectin-3 |
4 |
|
gender ratio |
4 |
|
gender selection |
4 |
|
genetic predisposition to disease |
4 |
|
glycoproteins - chemistry - genetics - metabolism |
4 |
|
green tea |
4 |
|
hmg |
4 |
|
homozygous a° thal |
4 |
|
hong kong - epidemiology |
4 |
|
hormonal profile |
4 |
|
human chorionic gonadotrophin |
4 |
|
hydrogen-ion concentration |
4 |
|
hyperprolactinemia |
4 |
|
hypogonadotrophic hypogonadism |
4 |
|
hysterectomy |
4 |
|
icsi |
4 |
|
in vitro fertilisation |
4 |
|
in vitro maturation |
4 |
|
in-law conflict |
4 |
|
in-vitro fertilisation |
4 |
|
infertility - blood - diagnosis - therapy |
4 |
|
infertility, female - genetics |
4 |
|
infertility, female - therapy |
4 |
|
infertility, male |
4 |
|
inhibin b |
4 |
|
inhibins - blood |
4 |
|
insemination, artificial - methods |
4 |
|
intimate partner violence, |
4 |
|
intrauterine devices, medicated |
4 |
|
intrauterine insemination |
4 |
|
intrauterine lidocaine |
4 |
|
isolated polycystic ovaries |
4 |
|
ivf-embryo transfer |
4 |
|
laparoscopy |
4 |
|
letrozole pretreatment |
4 |
|
levonorgestrel intrauterine system |
4 |
|
lidocaine gel |
4 |
|
literature review |
4 |
|
live birth |
4 |
|
live-birth |
4 |
|
luteal phase |
4 |
|
luteal phase support |
4 |
|
luteinizing hormone - blood |
4 |
|
male infertility |
4 |
|
male preference |
4 |
|
marital status |
4 |
|
metabolic syndrome |
4 |
|
method comparison |
4 |
|
microarray |
4 |
|
misoprostol - administration & dosage - adverse effects |
4 |
|
misoprostol - pharmacokinetics |
4 |
|
mitochondria - drug effects - metabolism |
4 |
|
mitochondrial dna copy number |
4 |
|
mutation |
4 |
|
natural family planning |
4 |
|
normal ovarian responders |
4 |
|
normal saline |
4 |
|
nt |
4 |
|
nuchal translucency |
4 |
|
olfactomedin |
4 |
|
oligomenorrhea - blood - diagnosis - etiology |
4 |
|
oocyte |
4 |
|
oocytes - drug effects - metabolism |
4 |
|
oocytes - physiology |
4 |
|
orlistat |
4 |
|
osmolar concentration |
4 |
|
ovarian reserve |
4 |
|
ovarian response markers |
4 |
|
ovarian response prediction index |
4 |
|
ovary - drug effects |
4 |
|
pain relief |
4 |
|
papp-a |
4 |
|
paternal age |
4 |
|
pcr |
4 |
|
pdia3 |
4 |
|
peptide fragments - pharmacology |
4 |
|
perpetrator |
4 |
|
pgd |
4 |
|
pharmacokinetics |
4 |
|
poor responders |
4 |
|
population control |
4 |
|
post-traumatic stress disorder |
4 |
|
posttraumatic stress disorder |
4 |
|
pre-pregnancy |
4 |
|
precision |
4 |
|
predictive value of tests |
4 |
|
pregnancy - psychology |
4 |
|
pregnancy and violence |
4 |
|
pregnancy complications - epidemiology - psychology |
4 |
|
pregnancy trimester, first - blood |
4 |
|
pregnancy-associated plasma protein-a - metabolism |
4 |
|
pregnant women - psychology |
4 |
|
preimplantation diagnosis - methods |
4 |
|
progestins - pharmacology |
4 |
|
progestogen-only injectable |
4 |
|
progestogen-only pill |
4 |
|
prolactin - blood |
4 |
|
punishment - psychology |
4 |
|
randomized controlled trial |
4 |
|
rats |
4 |
|
rats, sprague-dawley |
4 |
|
receptor activity-modifying protein 1 - metabolism |
4 |
|
receptor activity-modifying protein 2 - metabolism |
4 |
|
receptor activity-modifying protein 3 - metabolism |
4 |
|
recurrence |
4 |
|
reproductive techniques, assisted |
4 |
|
revised conflict tactics scale |
4 |
|
saline contrast sonohysterography |
4 |
|
saline infusion sonogram |
4 |
|
second trimester |
4 |
|
semen - physiology |
4 |
|
sequence deletion |
4 |
|
sibutramine |
4 |
|
soluble receptor of advanced glycation end-products |
4 |
|
sperm |
4 |
|
sperm motility - drug effects |
4 |
|
sperm-ovum interactions - drug effects - physiology |
4 |
|
spermatozoa - drug effects - metabolism - pathology - physiology |
4 |
|
spermatozoa - drug effects - physiology |
4 |
|
spouse abuse |
4 |
|
spouse abuse - psychology |
4 |
|
spouse abuse - statistics and numerical data |
4 |
|
steroid hormones |
4 |
|
stimulated cycle |
4 |
|
subfertility |
4 |
|
termination of pregnancy |
4 |
|
thalassaemia |
4 |
|
thiol-disulphide exchange |
4 |
|
three-dimensional power doppler |
4 |
|
twins |
4 |
|
uncoupling agents - pharmacology |
4 |
|
unfertilized oocyte |
4 |
|
up-regulation - drug effects |
4 |
|
violence - statistics and numerical data |
4 |
|
young adult |
4 |
|
zona pellucida - drug effects - metabolism |
4 |
|
3d power doppler |
3 |
|
abortifacient agents - administration and dosage |
3 |
|
abortifacient agents, steroidal - administration & dosage - adverse effects |
3 |
|
abortion, induced - methods - standards |
3 |
|
administration, intravaginal |
3 |
|
administration, sublingual |
3 |
|
age factors |
3 |
|
alpha-thalassemia - pathology - ultrasonography |
3 |
|
amenorrhea - drug therapy |
3 |
|
androstenedione - metabolism |
3 |
|
aneuploidy |
3 |
|
anovulation |
3 |
|
antibodies - analysis |
3 |
|
antiobesity drugs |
3 |
|
aric |
3 |
|
aromatase inhibitors - administration and dosage - therapeutic use |
3 |
|
arteries - physiopathology |
3 |
|
arthritis |
3 |
|
arthritis, rheumatoid |
3 |
|
artificial insemination |
3 |
|
assisted hatching |
3 |
|
autoantibodies |
3 |
|
azf |
3 |
|
biology |
3 |
|
biopsy |
3 |
|
blast analysis |
3 |
|
blood loss |
3 |
|
body mass index |
3 |
|
brca2 novel deletion |
3 |
|
breast cancer |
3 |
|
ca-125 |
3 |
|
ca-125 antigen - metabolism |
3 |
|
calcium ionophore |
3 |
|
cervix mucus - cytology |
3 |
|
china |
3 |
|
china - epidemiology |
3 |
|
chorionic gonadotropin - administration & dosage |
3 |
|
chorionic gonadotropin - administration & dosage - therapeutic use |
3 |
|
chromosomes, human, y - genetics |
3 |
|
cleavage stage embryo |
3 |
|
clinical pregnancy |
3 |
|
clomiphene - pharmacology |
3 |
|
coculture |
3 |
|
coculture techniques |
3 |
|
cohort studies |
3 |
|
color signals |
3 |
|
computer-aided sperm analysis |
3 |
|
contraceptives |
3 |
|
contraceptives, oral, combined |
3 |
|
contraceptives, oral, hormonal |
3 |
|
cycle-to-cycle variation |
3 |
|
cytokines |
3 |
|
diagnosis, computer-assisted |
3 |
|
diagnosis, differential |
3 |
|
dna - chemistry - genetics |
3 |
|
doppler haemodynamics |
3 |
|
doppler hemodynamics |
3 |
|
double-blind method |
3 |
|
drug therapy, combination |
3 |
|
early pregnancy |
3 |
|
ectopic pregnancy |
3 |
|
embryo |
3 |
|
embryo quality |
3 |
|
embryo transfer - statistics & numerical data |
3 |
|
emergency contraception |
3 |
|
endometrial and subendometrial blood flow |
3 |
|
endometrial and subendometrial blood flows |
3 |
|
endometrial blood flow |
3 |
|
endometrial morphometry |
3 |
|
endometrial perfusion |
3 |
|
endometrium - blood supply |
3 |
|
endometrium - chemistry |
3 |
|
endometrium - drug effects - ultrasonography |
3 |
|
endometrium - metabolism - ultrasonography |
3 |
|
endometrium - pathology |
3 |
|
endometrium - ultrasonography |
3 |
|
estradiol |
3 |
|
estrogens - urine |
3 |
|
excessive ovarian responses |
3 |
|
excessive responders |
3 |
|
fallopian tube patency tests - methods |
3 |
|
fallopian tubes |
3 |
|
fertile women |
3 |
|
fertilization in vitro - methods |
3 |
|
fetal anemia |
3 |
|
fetal diseases - pathology - ultrasonography |
3 |
|
fibroids |
3 |
|
first trimester medical abortions |
3 |
|
follicle stimulating hormone - administration & dosage - adverse effects |
3 |
|
forecasting |
3 |
|
frozen thawed embryo transfer |
3 |
|
fsh/administration & dosage |
3 |
|
gestational diabetes |
3 |
|
glutamine |
3 |
|
glycoprotein |
3 |
|
glycoproteins - metabolism |
3 |
|
hb-bart's disease |
3 |
|
hemizona binding assay |
3 |
|
hemodynamics |
3 |
|
hepatitis b surface antigen |
3 |
|
hepatitis b surface antigens - analysis |
3 |
|
hepatitis b, chronic - physiopathology - transmission |
3 |
|
high oestradiol |
3 |
|
high responders |
3 |
|
homozygous α 0-thalassemia |
3 |
|
hormonal |
3 |
|
hormone profile |
3 |
|
hormone replacement therapy |
3 |
|
human menopausal gonadotrophin. |
3 |
|
huntington disease |
3 |
|
hydrosalpinx |
3 |
|
hydrosalpinx fluid |
3 |
|
hysterosalpingography |
3 |
|
imaging, three-dimensional |
3 |
|
immunoenzyme techniques |
3 |
|
implantation rate |
3 |
|
in vitro fertilization/embryo transfer |
3 |
|
induction of ovulation |
3 |
|
infectious disease transmission, vertical |
3 |
|
infertility - drug therapy - metabolism |
3 |
|
infertility - therapy |
3 |
|
infertility, female |
3 |
|
infertility, female - blood - drug therapy - physiopathology |
3 |
|
infertility, female - diagnosis |
3 |
|
infertility, male - epidemiology - genetics |
3 |
|
infertility, male - genetics |
3 |
|
insemination |
3 |
|
insemination, artificial |
3 |
|
insemination, artificial, homologous |
3 |
|
insemination, artificial, husband |
3 |
|
interleukin-11 - analysis |
3 |
|
interleukin-4 - analysis |
3 |
|
interleukin-6 - analysis |
3 |
|
intramuscular |
3 |
|
isojima sperm immobilization test |
3 |
|
isolate |
3 |
|
ivf treatment |
3 |
|
ixaprep |
3 |
|
lactate |
3 |
|
laser |
3 |
|
laser assisted hatching |
3 |
|
leukemia inhibitory factor |
3 |
|
live-birth rate |
3 |
|
logistic models |
3 |
|
lorcaserin |
3 |
|
lupus erythematosus |
3 |
|
lupus erythematosus, systemic |
3 |
|
male subfertility |
3 |
|
menotropins - administration & dosage |
3 |
|
menotropins - administration and dosage - therapeutic use |
3 |
|
menstrual cycle - physiology |
3 |
|
menstrual pattern |
3 |
|
menstruation disturbances - drug therapy |
3 |
|
mifepristone - administration & dosage - adverse effects |
3 |
|
mifepristone - administration and dosage |
3 |
|
misoprostol - administration and dosage |
3 |
|
mosaicism |
3 |
|
motile sperm recovery |
3 |
|
multiple pregnancy rate |
3 |
|
nitriles - administration and dosage |
3 |
|
nitriles - administration and dosage - therapeutic use |
3 |
|
non-obstructive azoospermia |
3 |
|
number of embryos replaced |
3 |
|
nurses |
3 |
|
obese |
3 |
|
observer variation |
3 |
|
oestradiol |
3 |
|
ohss |
3 |
|
oligomenorrhea - drug therapy |
3 |
|
oligospermia - epidemiology - genetics |
3 |
|
oligospermia - genetics |
3 |
|
oocyte and embryo quality |
3 |
|
oocyte fusion |
3 |
|
oocyte quality |
3 |
|
oral |
3 |
|
organ size |
3 |
|
outcome assessment (health care) |
3 |
|
ovarian sensitivity index |
3 |
|
ovarian stimulation syndrome |
3 |
|
ovarian volume |
3 |
|
ovary |
3 |
|
ovary - blood supply |
3 |
|
pain measurement |
3 |
|
percoll |
3 |
|
perifollicular vascularity |
3 |
|
phentermine/topiramate |
3 |
|
pituitary downregulation |
3 |
|
placebo |
3 |
|
placebos |
3 |
|
placenta |
3 |
|
placenta - pathology - ultrasonography |
3 |
|
polycystic ovaries |
3 |
|
poor ovarian responders |
3 |
|
poor ovarian response |
3 |
|
poor ovarian responses |
3 |
|
post-ovulatory |
3 |
|
power doppler |
3 |
|
pp14 |
3 |
|
pre-ovulatory |
3 |
|
pregnancy - statistics & numerical data |
3 |
|
pregnancy proteins - metabolism |
3 |
|
prepregnancy |
3 |
|
probability |
3 |
|
prognosis |
3 |
|
pulsatile flow |
3 |
|
pulse |
3 |
|
pyruvate |
3 |
|
recombinant human fsh |
3 |
|
recombinant proteins - administration & dosage - adverse effects |
3 |
|
recombinant proteins/administration & dosage |
3 |
|
reference values |
3 |
|
regional blood flow |
3 |
|
reproduction techniques |
3 |
|
results |
3 |
|
rheumatic diseases |
3 |
|
rheumatoid |
3 |
|
sampling studies |
3 |
|
second trimester abortion |
3 |
|
second trimester medical abortion |
3 |
|
second-trimester medical abortion |
3 |
|
secretory phase endometrium |
3 |
|
sensitivity and specificity |
3 |
|
sequence tagged sites |
3 |
|
sex chromosome aberrations |
3 |
|
sexual abstinence |
3 |
|
specimen handling |
3 |
|
sperm agglutination |
3 |
|
sperm haplotyping |
3 |
|
sperm immobilization kibrick sperm agglutination test |
3 |
|
sperm macroagglutination |
3 |
|
sperm motility and velocities |
3 |
|
sperm separation |
3 |
|
spermatozoa - immunology |
3 |
|
statistics, nonparametric |
3 |
|
stimulation |
3 |
|
stimulation cycles |
3 |
|
stromal blood flow |
3 |
|
subcutaneous |
3 |
|
subendometrial blood flow |
3 |
|
suboptimal endometrium |
3 |
|
systemic |
3 |
|
testicular sperm extraction |
3 |
|
testosterone - blood |
3 |
|
th2 cells - metabolism |
3 |
|
therapeutic irrigation |
3 |
|
three-dimensional hysterosalpingo-contrast- sonography |
3 |
|
transvaginal ultrasound |
3 |
|
triazoles - administration and dosage - therapeutic use |
3 |
|
ultrasonography, doppler - methods |
3 |
|
ultrasonography, doppler, color |
3 |
|
ultrasonography, prenatal |
3 |
|
ultrasonography, prenatal - methods - standards |
3 |
|
uterine blood flow |
3 |
|
uterine doppler flow |
3 |
|
uterine flushing |
3 |
|
uterus - blood supply |
3 |
|
vagina |
3 |
|
vagina - cytology |
3 |
|
vascular resistance |
3 |
|
volume |
3 |
|
whole genome amplification |
3 |
|
y chromosome |
3 |
|
y chromosome microdeletion |
3 |
|
zona breaching and zona thinning |
3 |
|
3-dimensional power doppler ultrasonography |
2 |
|
3d |
2 |
|
abdominal pain - drug therapy |
2 |
|
abnormal luteal phase |
2 |
|
abortifacient agents - pharmacology |
2 |
|
abortifacient agents, nonsteroidal - administration & dosage |
2 |
|
abortifacient agents, nonsteroidal - pharmacology |
2 |
|
abortifacient agents, steroidal - adverse effects - therapeutic use |
2 |
|
abortifacient agents, steroidal - pharmacology |
2 |
|
abortion, induced - statistics and numerical data |
2 |
|
abortion, spontaneous - blood |
2 |
|
abortion, spontaneous - blood - chemically induced - diagnosis |
2 |
|
abortions |
2 |
|
administration, intranasal |
2 |
|
aged |
2 |
|
ageing |
2 |
|
aging |
2 |
|
alprostadil - analogs & derivatives |
2 |
|
androgen receptor antagonists |
2 |
|
anesthesia, obstetrical |
2 |
|
anesthetics, local - administration & dosage - therapeutic use |
2 |
|
anti-estrogen effect of clomiphene |
2 |
|
antibodies, monoclonal |
2 |
|
antifungal therapy |
2 |
|
antigens, cd - analysis |
2 |
|
antigens, cd4 - analysis |
2 |
|
antral follicles |
2 |
|
anxiety |
2 |
|
asia |
2 |
|
asia - epidemiology |
2 |
|
asian women |
2 |
|
assisted reproductive technology |
2 |
|
assisted-reproduction technology |
2 |
|
atrial fibrillation |
2 |
|
atrial fibrillation - complications - therapy |
2 |
|
atrial function, left |
2 |
|
atrial function, right |
2 |
|
autoantibodies - analysis |
2 |
|
autoimmune diseases - etiology |
2 |
|
b-lymphocyte subsets - immunology |
2 |
|
b-lymphocytes - pathology |
2 |
|
basal metabolism |
2 |
|
blastocyst - physiology |
2 |
|
blood culture |
2 |
|
blood flow velocity |
2 |
|
buccal |
2 |
|
buserelin - administration & dosage |
2 |
|
candida glabrata |
2 |
|
candidemia |
2 |
|
cardiac output |
2 |
|
cardiac pacing, artificial - methods |
2 |
|
caspase |
2 |
|
caspases |
2 |
|
cd4-cd8 ratio |
2 |
|
cell count |
2 |
|
cell fusion |
2 |
|
cerebral cortex - blood supply |
2 |
|
cerebral hemorrhage |
2 |
|
cervix mucus - analysis |
2 |
|
cervix uteri - drug effects |
2 |
|
chinese men |
2 |
|
chlamydia trachomatis antibody |
2 |
|
chorionic gonadotropin - administration & dosage - blood - pharmacology |
2 |
|
chorionic gonadotropin - blood |
2 |
|
chorionic gonadotropin - pharmacology |
2 |
|
chorionic gonadotropin, beta subunit, human |
2 |
|
circadian rhythm |
2 |
|
clinical protocols |
2 |
|
clinically recognizable pregnancies, plasma progesterone levels |
2 |
|
clomiphene |
2 |
|
clomiphene - adverse effects - analogs & derivatives - therapeutic use |
2 |
|
clomiphene - therapeutic use |
2 |
|
clomiphene citrate |
2 |
|
clomiphene citrate challenge test |
2 |
|
clomiphene-resistant |
2 |
|
co-culture |
2 |
|
co-incubation |
2 |
|
conscious sedation |
2 |
|
copper intrauterine device |
2 |
|
cricetinae |
2 |
|
crinone |
2 |
|
culture media |
2 |
|
culture media - chemistry - metabolism |
2 |
|
culture media, conditioned |
2 |
|
culture techniques |
2 |
|
cumulus cells |
2 |
|
cyclogest |
2 |
|
decidua - metabolism |
2 |
|
dehydroepiandrosterone sulfate - blood |
2 |
|
demography |
2 |
|
designer babies |
2 |
|
developing countries |
2 |
|
dilatation - methods |
2 |
|
dilation and evacuation |
2 |
|
discriminant analysis |
2 |
|
doppler ultrasound |
2 |
|
dual-site right atrial pacing |
2 |
|
early development |
2 |
|
echocardiography |
2 |
|
echocardiography, doppler |
2 |
|
egg collection |
2 |
|
embryo development |
2 |
|
embryo editing |
2 |
|
embryo, mammalian - metabolism |
2 |
|
embryos |
2 |
|
embryotrophic factor |
2 |
|
endometrial vascularity |
2 |
|
engineering nuclease |
2 |
|
estrogen replacement therapy |
2 |
|
estrogens - deficiency |
2 |
|
ethnic groups |
2 |
|
ethnic origin |
2 |
|
fallopian tube diseases - complications - physiopathology |
2 |
|
fallopian tubes - cytology |
2 |
|
fallopian tubes - cytology - physiology |
2 |
|
fallopian tubes - physiology |
2 |
|
far east |
2 |
|
fertility agents, female |
2 |
|
fertility agents, female - therapeutic use |
2 |
|
fertilization, delayed |
2 |
|
fertilizaton in vitro |
2 |
|
fetal viability |
2 |
|
follicle stimulating hormone (fsh) |
2 |
|
follicle stimulating hormone - administration & dosage |
2 |
|
follicle stimulating hormone - administration & dosage - blood |
2 |
|
follicular vascularity |
2 |
|
fragmentation |
2 |
|
fsh |
2 |
|
gemeprost |
2 |
|
genital diseases, female - diagnosis |
2 |
|
gnrh agonist |
2 |
|
gnrh antagonist |
2 |
|
gonadal dysgenesis - immunology |
2 |
|
gonadotropins |
2 |
|
gonadotropins - therapeutic use |
2 |
|
heart atria - ultrasonography |
2 |
|
herbal medicine |
2 |
|
human |
2 |
|
human chorionic gonadotrophin beta-subunit |
2 |
|
human follicular fluid |
2 |
|
hyperactivation |
2 |
|
hypoglycemic agents - therapeutic use |
2 |
|
iliac vein |
2 |
|
immunoglobulin g - blood |
2 |
|
immunoglobulins |
2 |
|
immunoglobulins - blood |
2 |
|
immunohistochemistry |
2 |
|
in vitro fertilization (ivf) |
2 |
|
in vitro fertilization: pregnancy, three-dimensional ultrasound |
2 |
|
infertility, female - drug therapy - physiopathology |
2 |
|
infertility, female - etiology |
2 |
|
infertility, female - physiopathology |
2 |
|
infertility, male - ethnology - pathology |
2 |
|
infertility, male - etiology |
2 |
|
infertility, male - physiopathology |
2 |
|
infertility, male - therapy |
2 |
|
interleukin-1 - analysis - metabolism |
2 |
|
intracranial thrombosis - diagnosis - etiology |
2 |
|
left atrial function |
2 |
|
leucocytospermia |
2 |
|
leukocyte count |
2 |
|
leukocytes - immunology |
2 |
|
lh surge |
2 |
|
lidocaine - administration & dosage - therapeutic use |
2 |
|
lignocaine |
2 |
|
luteal phase - drug effects |
2 |
|
luteinizing hormone (lh) |
2 |
|
luteinizing hormone - secretion |
2 |
|
lymphocyte subsets |
2 |
|
lymphocytes |
2 |
|
lymphocytes - classification |
2 |
|
magnetic resonance imaging |
2 |
|
male factor |
2 |
|
medical treatment |
2 |
|
medium |
2 |
|
menopause - immunology |
2 |
|
menopause, premature - blood - immunology |
2 |
|
menotropins - adverse effects |
2 |
|
microscopy, phase-contrast |
2 |
|
mifepristone - adverse effects - therapeutic use |
2 |
|
mifepristone - pharmacology |
2 |
|
miscarriages |
2 |
|
misoprostol - administration & dosage |
2 |
|
missed miscarriage |
2 |
|
monitoring, physiologic |
2 |
|
monogenic diseases |
2 |
|
multiple doses |
2 |
|
n2o |
2 |
|
natural/ovarian stimulation cycles |
2 |
|
next-generation sequencing (ngs) |
2 |
|
nitric oxide donor |
2 |
|
non-inferiority randomised trial |
2 |
|
oestrogen deficiency |
2 |
|
oestrogen replacement |
2 |
|
oocyte retrieval |
2 |
|
oocytes |
2 |
|
oocytes - cytology |
2 |
|
oral misoprostol |
2 |
|
ovarian cysts - etiology |
2 |
|
ovarian cysts - ultrasonography |
2 |
|
ovarian diseases - immunology |
2 |
|
ovarian diseases - immunology - metabolism |
2 |
|
ovarian follicle - ultrasonography |
2 |
|
ovarian function |
2 |
|
ovarian hyperstimulation syndrome - chemically induced - ultrasonography |
2 |
|
ovarian hyperstimulation syndrome - complications |
2 |
|
ovary - blood supply - drug effects - ultrasonography |
2 |
|
ovary - blood supply - metabolism - surgery |
2 |
|
ovary - blood supply - ultrasonography |
2 |
|
ovary - ultrasonography |
2 |
|
oviduct |
2 |
|
oviductal cells |
2 |
|
ovulation |
2 |
|
oxygen |
2 |
|
pacemaker, artificial |
2 |
|
pain |
2 |
|
paracervical block |
2 |
|
patient convenience |
2 |
|
patient selection |
2 |
|
peptide fragments - administration & dosage - blood - pharmacology |
2 |
|
peptide fragments - blood |
2 |
|
percoll gradient centrifugation |
2 |
|
pituitary gland - drug effects - physiopathology |
2 |
|
placenta - metabolism |
2 |
|
plasma fraction |
2 |
|
plasmanate |
2 |
|
polycystic ovary only |
2 |
|
polycystic ovary syndrome - diagnosis - ethnology - metabolism - therapy |
2 |
|
polycystic ovary syndrome - ultrasonography |
2 |
|
polymerase chain reaction (pcr) |
2 |
|
polyploidy |
2 |
|
population |
2 |
|
population characteristics |
2 |
|
postcoital contraception |
2 |
|
postoperative side effects |
2 |
|
postoperative side-effects |
2 |
|
postpartum period |
2 |
|
prediction of ovarian response |
2 |
|
pregnancy proteins - analysis |
2 |
|
pregnancy test |
2 |
|
pregnancy, multiple |
2 |
|
pregnancy-specific beta 1-glycoproteins - analysis |
2 |
|
preimplantation genetic diagnosis (pgd) |
2 |
|
premedication |
2 |
|
primary ovarian insufficiency - drug therapy - immunology |
2 |
|
progesterone - administration & dosage - pharmacology - therapeutic use |
2 |
|
progesterone - blood |
2 |
|
prolactin - analysis - blood |
2 |
|
pronuclear stage tubal transfer (prost) |
2 |
|
prostaglandins e, synthetic - adverse effects - pharmacology |
2 |
|
protein |
2 |
|
protein supplement |
2 |
|
radio-ligand technique measurement |
2 |
|
radioimmunoassay |
2 |
|
randomized trial |
2 |
|
reaction time |
2 |
|
receptors, estrogen - antagonists & inhibitors |
2 |
|
receptors, glucocorticoid - metabolism |
2 |
|
receptors, progesterone - metabolism |
2 |
|
receptors, steroid - metabolism |
2 |
|
reproduction |
2 |
|
salpingectomy |
2 |
|
second trimester termination |
2 |
|
semen - cytology |
2 |
|
seminal leucocytes |
2 |
|
serum |
2 |
|
severe ohss |
2 |
|
side effects |
2 |
|
single dose |
2 |
|
sodium nitroprusside |
2 |
|
sperm capacitation |
2 |
|
sperm count |
2 |
|
sperm functions |
2 |
|
sperm-ovum interactions |
2 |
|
spermatozoa - abnormalities |
2 |
|
spermatozoa - cytology - physiology |
2 |
|
spermatozoa - physiology |
2 |
|
spouse abuse - psychology - statistics and numerical data |
2 |
|
stimulated ovulation |
2 |
|
suction evacuation |
2 |
|
suppositories |
2 |
|
suppositories - adverse effects |
2 |
|
surgical termination of pregnancy |
2 |
|
t cells |
2 |
|
t-lymphocyte subsets - immunology |
2 |
|
therapeutics |
2 |
|
three-dimensional power doppler ultrasonography |
2 |
|
tissue and organ harvesting - methods |
2 |
|
transabdominal ultrasound |
2 |
|
tubal factor |
2 |
|
tubal pathology |
2 |
|
ultrasonographic parameters |
2 |
|
ultrasonography |
2 |
|
ultrasound |
2 |
|
unprotected intercourse |
2 |
|
uterine artery blood flow |
2 |
|
uterine fibroids |
2 |
|
uterus - blood supply - ultrasonography |
2 |
|
vacuum curettage |
2 |
|
vaginal |
2 |
|
vaginal creams, foams, and jellies - adverse effects |
2 |
|
vaginal progesterone |
2 |
|
vascular thrombosis |
2 |
|
vena cava, inferior |
2 |
|
venous thrombosis - diagnosis - etiology |
2 |
|
ventricular function |
2 |
|
who group ii anovulation |
2 |
|
zygote - physiology |
2 |
|
早孕 |
2 |
|
米索前列醇 (misoprostol) |
2 |
|
米非司酮 (mifepristone) |
2 |
|
舌下含服 (sublingual swallowing) |
2 |
|
药物流产 |
2 |
|
abnormalities, multiple - diagnosis |
1 |
|
abortifacient agents - adverse effects |
1 |
|
abortifacient agents, nonsteroidal |
1 |
|
abortifacient agents, nonsteroidal - administration & dosage - adverse effects - pharmacology |
1 |
|
abortifacient agents, nonsteroidal - administration & dosage - pharmacology - standards |
1 |
|
abortifacient agents, nonsteroidal - administration and dosage - pharmacokinetics |
1 |
|
abortifacient agents, nonsteroidal - adverse effects |
1 |
|
abortifacient agents, steroidal - administration & dosage |
1 |
|
abortifacient agents, steroidal - administration & dosage - adverse effects - pharmacology |
1 |
|
abortion |
1 |
|
abortion, induced - standards |
1 |
|
abortion, therapeutic |
1 |
|
abortion, therapeutic - methods |
1 |
|
abortion, threatened - blood |
1 |
|
acceptability |
1 |
|
adaptation, psychological |
1 |
|
adjuvants, immunologic - therapeutic use |
1 |
|
administration, oral |
1 |
|
advanced provision |
1 |
|
alprostadil - administration & dosage - adverse effects - analogs & derivatives |
1 |
|
alprostadil - administration & dosage - analogs & derivatives |
1 |
|
alprostadil - administration & dosage - analogs & derivatives - pharmacology - standards |
1 |
|
alprostadil - adverse effects - analogs & derivatives |
1 |
|
amenorrhea |
1 |
|
anembryonic pregnancy |
1 |
|
antibodies, monoclonal - diagnostic use |
1 |
|
antigen-antibody complex - analysis |
1 |
|
antigens - analysis |
1 |
|
antigens, differentiation, t-lymphocyte - analysis |
1 |
|
antineoplastic combined chemotherapy protocols - therapeutic use |
1 |
|
antiprogestins |
1 |
|
apgar score |
1 |
|
assisted reproductive technologies |
1 |
|
atretic cervix and vagina |
1 |
|
attitude to health |
1 |
|
attitudes |
1 |
|
autoimmunity - physiology |
1 |
|
b-lymphocytes |
1 |
|
b-lymphocytes - immunology |
1 |
|
bacterial infections - prevention & control |
1 |
|
binding, competitive |
1 |
|
birth weight |
1 |
|
blood bactericidal activity |
1 |
|
blood cell count |
1 |
|
blood coagulation factors - analysis |
1 |
|
blood loss, surgical |
1 |
|
body temperature |
1 |
|
brain neoplasms - secondary |
1 |
|
bromocriptine - administration & dosage |
1 |
|
bromocriptine retard |
1 |
|
candida albicans |
1 |
|
cervical priming |
1 |
|
cervical ripening |
1 |
|
cervix |
1 |
|
cervix mucus |
1 |
|
cervix mucus - physiology |
1 |
|
cervix uteri - abnormalities |
1 |
|
cervix uteri - drug effects - physiology |
1 |
|
cesarean section - methods |
1 |
|
chemotaxis, leukocyte |
1 |
|
chinese puerpera |
1 |
|
cholesterol - blood |
1 |
|
choriocarcinoma |
1 |
|
choriocarcinoma - immunology |
1 |
|
chorion - analysis - anatomy & histology - ultrastructure |
1 |
|
chorionic gonadotropin - analysis |
1 |
|
chorionic gonadotropin - blood - cerebrospinal fluid |
1 |
|
clomiphene - administration & dosage |
1 |
|
colostrum - cytology |
1 |
|
comparative study |
1 |
|
congresses as topic |
1 |
|
contraception |
1 |
|
contraception - psychology |
1 |
|
contraception, postcoital - methods - psychology - utilization |
1 |
|
contraceptive agents, female - administration & dosage - adverse effects |
1 |
|
contraceptive agents, male |
1 |
|
contraceptive behaviour |
1 |
|
contraceptive pill |
1 |
|
contraceptives, oral |
1 |
|
contraceptives, oral, synthetic - administration & dosage - adverse effects |
1 |
|
contraceptives, postcoital |
1 |
|
contraceptives, postcoital - administration & dosage |
1 |
|
contraceptives, postcoital - therapeutic use |
1 |
|
cross-cultural comparison |
1 |
|
cultural setting |
1 |
|
cytotoxicity tests, immunologic |
1 |
|
delayed-action preparations |
1 |
|
delivery, obstetric |
1 |
|
desogestrel |
1 |
|
diarrhea - chemically induced |
1 |
|
digoxin - therapeutic use |
1 |
|
dilatation and curettage |
1 |
|
dinoprostone - analogs & derivatives |
1 |
|
domestic violence |
1 |
|
drug administration schedule |
1 |
|
drug combinations |
1 |
|
drug interactions |
1 |
|
drug synergism |
1 |
|
elderly primipara |
1 |
|
embryo transfer - adverse effects |
1 |
|
endometrium - drug effects - pathology |
1 |
|
england |
1 |
|
escherichia coli |
1 |
|
estrogens - blood |
1 |
|
estrogens - physiology |
1 |
|
ethinyl estradiol - administration & dosage - adverse effects - therapeutic use |
1 |
|
evaluation studies as topic |
1 |
|
expectant management |
1 |
|
factor viii - analysis - immunology |
1 |
|
factor viii-related antigen |
1 |
|
fallopian tubes - surgery |
1 |
|
false negative reactions |
1 |
|
false positive reactions |
1 |
|
family planning services |
1 |
|
fetal membranes, premature rupture - therapy |
1 |
|
fluorescent antibody technique |
1 |
|
freezing |
1 |
|
gamete intrafallopian transfer |
1 |
|
gamete intrafallopian transfer (gift) |
1 |
|
gender identity |
1 |
|
genital tract anomaly |
1 |
|
gestational trophoblastic tumors |
1 |
|
gestational trophoblastic tumours. |
1 |
|
glycoproteins |
1 |
|
hamster egg penetration assay |
1 |
|
health services accessibility |
1 |
|
heart defects, congenital - drug therapy |
1 |
|
heart diseases - drug therapy |
1 |
|
hemagglutination inhibition tests |
1 |
|
hemagglutination tests |
1 |
|
hematometra |
1 |
|
hematometra - etiology |
1 |
|
hemoglobins - analysis |
1 |
|
hla antigens - analysis |
1 |
|
hla-a antigens |
1 |
|
hla-b antigens |
1 |
|
hong kong - ethnology |
1 |
|
hormonal contraception |
1 |
|
hormones - physiology |
1 |
|
human rights |
1 |
|
human sperm |
1 |
|
hydatidiform mole |
1 |
|
hydatidiform mole - blood - surgery |
1 |
|
hydatidiform mole - drug therapy - immunology |
1 |
|
hydatidiform mole - immunology |
1 |
|
hydatidiform mole - immunology - therapy |
1 |
|
hydatidiform mole - physiopathology - therapy |
1 |
|
hydatidiform mole - therapy |
1 |
|
hypoosmotic swelling |
1 |
|
hypo‐osmotic treatment |
1 |
|
hysterectomy - psychology |
1 |
|
identification (psychology) |
1 |
|
immune tolerance |
1 |
|
immunodiffusion |
1 |
|
immunoelectrophoresis |
1 |
|
immunoglobulin a - metabolism |
1 |
|
incomplete abortion |
1 |
|
infant, low birth weight |
1 |
|
infant, newborn |
1 |
|
infant, newborn, diseases - prevention & control |
1 |
|
infertility, male - diagnosis |
1 |
|
insemination, artificial, heterologous |
1 |
|
insemination, artificial, heterologous - methods |
1 |
|
interviews as topic |
1 |
|
intrauterine death |
1 |
|
isoantigens - immunology |
1 |
|
killer cells, natural - immunology |
1 |
|
knowledge |
1 |
|
knowledge, attitudes, practice |
1 |
|
labor, induced |
1 |
|
labor, obstetric |
1 |
|
lactation - drug effects |
1 |
|
leucine - analogs & derivatives - therapeutic use |
1 |
|
leukocytes - physiology |
1 |
|
levonorgestrel - administration & dosage - adverse effects |
1 |
|
levonorgestrel - adverse effects - therapeutic use |
1 |
|
lipids - blood |
1 |
|
luteinizing hormone (lh) assays |
1 |
|
luteinizing hormone - blood - urine |
1 |
|
lymphocyte activation |
1 |
|
lymphocyte culture test, mixed |
1 |
|
lymphocytes - immunology |
1 |
|
lymphocytes - physiology |
1 |
|
male contraception |
1 |
|
measured blood loss |
1 |
|
medical |
1 |
|
medical management |
1 |
|
membranes - ultrastructure |
1 |
|
menorrhagia - chemically induced |
1 |
|
methotrexate - therapeutic use |
1 |
|
mifepristone - administration & dosage |
1 |
|
mifepristone - administration & dosage - adverse effects - pharmacology |
1 |
|
mifepristone - adverse effects |
1 |
|
mifepristone - adverse effects - pharmacology |
1 |
|
misoprostol - administration & dosage - adverse effects - pharmacology |
1 |
|
misoprostol - administration & dosage - pharmacology - standards |
1 |
|
misoprostol - administration and dosage - analogs and derivatives - blood - pharmacokinetics |
1 |
|
missed abortion |
1 |
|
mitogens - pharmacology |
1 |
|
mixed lymphocyte reaction |
1 |
|
multicenter studies as topic |
1 |
|
multivariate discriminant analysis |
1 |
|
natural killer cells |
1 |
|
neutrophils - physiology |
1 |
|
non-pregnant women |
1 |
|
norgestrel |
1 |
|
norgestrel - administration & dosage - adverse effects - therapeutic use |
1 |
|
normal pregnancy |
1 |
|
normal sperm morphology |
1 |
|
norpregnenes |
1 |
|
nsaid |
1 |
|
obstetric labor complications - etiology |
1 |
|
oc pills |
1 |
|
oestrogen |
1 |
|
oligospermia - immunology |
1 |
|
oligospermia - physiopathology |
1 |
|
once-a-month pill |
1 |
|
oral contraceptive pills |
1 |
|
ovarian diseases - pathology |
1 |
|
ovary - drug effects - physiopathology |
1 |
|
ovulation detection - methods |
1 |
|
oxytocics - administration & dosage |
1 |
|
oxytocin - administration & dosage |
1 |
|
parity |
1 |
|
pattern of menstrual bleeding |
1 |
|
peptide fragments - blood - cerebrospinal fluid |
1 |
|
perceptions |
1 |
|
pessaries |
1 |
|
phagocytes - physiology |
1 |
|
phagocytosis |
1 |
|
pilot projects |
1 |
|
placenta - analysis |
1 |
|
post-abortion bleeding |
1 |
|
post-coital contraception |
1 |
|
postmenopausal women |
1 |
|
postnatal depression |
1 |
|
postpartum hemorrhage |
1 |
|
pregnancy complications - blood |
1 |
|
pregnancy complications - etiology |
1 |
|
pregnancy complications, cardiovascular - blood |
1 |
|
pregnancy complications, cardiovascular - drug therapy |
1 |
|
pregnancy proteins - blood |
1 |
|
pregnancy trimester, first - drug effects |
1 |
|
pregnancy trimester, second - drug effects |
1 |
|
pregnancy, ectopic - blood |
1 |
|
pregnancy, ectopic - diagnosis |
1 |
|
pregnancy, high-risk |
1 |
|
pregnancy, tubal - diagnosis - etiology - surgery |
1 |
|
pregnancy, unwanted |
1 |
|
pregnancy-specific beta 1-glycoproteins - analysis - cerebrospinal fluid |
1 |
|
pregnancy-specific beta 1-glycoproteins - blood |
1 |
|
prostaglandin |
1 |
|
psychological tests |
1 |
|
psychometrics |
1 |
|
puerperal ablactation |
1 |
|
puerperium |
1 |
|
pyridoxine - administration & dosage |
1 |
|
randomized controlled trials as topic |
1 |
|
receptors, fc - immunology |
1 |
|
regression analysis |
1 |
|
reproducibility of results |
1 |
|
reproductive rights |
1 |
|
rheumatic heart disease - drug therapy |
1 |
|
risk |
1 |
|
risk-taking |
1 |
|
ru 486 |
1 |
|
second-trimester abortion |
1 |
|
second-trimester induced abortion |
1 |
|
semen analysis |
1 |
|
semen preservation |
1 |
|
sex behavior |
1 |
|
skin tests |
1 |
|
south africa |
1 |
|
sperm morphology |
1 |
|
sperm movement characteristics |
1 |
|
spermatozoa - abnormalities - physiology |
1 |
|
spermatozoa - cytology |
1 |
|
spontaneous |
1 |
|
sublingual misoprostol |
1 |
|
suction |
1 |
|
suction - adverse effects |
1 |
|
suction - methods |
1 |
|
t-lymphocytes |
1 |
|
t-lymphocytes - immunology |
1 |
|
t-lymphocytes - immunology - physiology |
1 |
|
tablets |
1 |
|
testis - cytology |
1 |
|
tolerability |
1 |
|
trophoblastic neoplasms - blood - cerebrospinal fluid - drug therapy |
1 |
|
trophoblastic neoplasms - blood - immunology |
1 |
|
trophoblastic neoplasms - drug therapy - immunology |
1 |
|
trophoblastic neoplasms - immunology |
1 |
|
trophoblastic tumors |
1 |
|
trophoblastic tumours |
1 |
|
uterine hemorrhage - blood |
1 |
|
uterine hemorrhage - chemically induced |
1 |
|
uterine hemorrhage - etiology |
1 |
|
uterine neoplasms - blood - cerebrospinal fluid - drug therapy |
1 |
|
uterine neoplasms - blood - immunology |
1 |
|
uterine neoplasms - blood - surgery |
1 |
|
uterine neoplasms - drug therapy - immunology |
1 |
|
uterine neoplasms - immunology |
1 |
|
uterine neoplasms - immunology - therapy |
1 |
|
uterine neoplasms - physiopathology - therapy |
1 |
|
uterus |
1 |
|
uterus - ultrasonography |
1 |
|
vacuum aspiration |
1 |
|
vacuum extraction, obstetrical |
1 |
|
vagina - abnormalities |
1 |
|
von willebrand factor |
1 |
|
von willebrand factor - analysis |
1 |
|
women - psychology |
1 |
|
women's attitudes |
1 |
|
yuzpe |
1 |
